Between new genetic discoveries and large randomized trials—neurological research in the era of systems medicine

Authors

  • Thomas Misgeld,

    1. Munich Cluster for Systems Neurology, German Centre for Neurodegenerative Diseases, Munich, Germany, Munich, Germany
    2. Technische Universität, München, Germany
    Search for more papers by this author
  • Stefan F Lichtenthaler,

    1. Munich Cluster for Systems Neurology, German Centre for Neurodegenerative Diseases, Munich, Germany, Munich, Germany
    2. Technische Universität, München, Germany
    Search for more papers by this author
  • Martin Dichgans

    1. Munich Cluster for Systems Neurology, German Centre for Neurodegenerative Diseases, Munich, Germany, Munich, Germany
    2. Institute for Stroke and Dementia Research, Ludwig-Maximilians-University, Munich, Germany
    Search for more papers by this author

Abstract

The 2012 Eibsee meeting on ‘Cellular Mechanisms of Neurodegeneration’ addressed the need to integrate research on classical neurodegenerative mechanisms with investigations that relate to the immunological, glial and vascular sequels that accompany and often propagate neuronal injury. We report on the central topics that were addressed and discuss future directions towards establishing ‘systems neurology’ as a new integrated research field.

Ancillary